Nuvectis Pharma, Inc.

NASDAQ:NVCT

Biotechnology

Healthcare
$19.84 +3.06%

+$0.39 today

Market cap
$682.28M
Beta
-0.07
P/E (TTM)
-11.2
EPS (TTM)
-$1.16
52W Low $5.55High $13.51

Volume 0.16M

Average 0.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$31.71M

FY 2025 · Annual

+70.4% YoY

Liabilities

$13.30M

FY 2025 · Annual

+49.5% YoY

Equity

$18.41M

FY 2025 · Annual

+89.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents5.74M19.99M19.13M18.53M31.63M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets91K412K59K74K75K
Total Current Assets5.83M20.41M19.19M18.61M31.71M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets824K0000
Total Non-current Assets824K0000
Total Assets6.66M20.41M19.19M18.61M31.71M
Account Payables1.06M2.91M2.77M2.5M6.27M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities142K2.38M3.8M5.56M6.91M
Total Current Liabilities2.42M6.19M6.98M8.89M13.3M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities15.25M0000
Total Non-current Liabilities15.25M0000
Total Liabilities17.67M6.19M6.98M8.89M13.3M
Common Stock00000
Retained Earnings(12.9M)(31.99M)(54.25M)(73.25M)(99.69M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(11.01M)14.22M12.2M9.71M18.41M
Total Debt00000
Net Debt(5.74M)(19.99M)(19.13M)(18.53M)(31.63M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$25.1M
Other Current$268.0K
Total Current Assets$25.4M
Total Assets$25.4M

Analysis

Selected assets total $25.4M for Latest. The largest visible component is Cash & Equivalents at $25.1M, about 98.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
EFFECTEFFECT filingAug 28, 2026
S-3S-3 filingAug 21, 2026
8-KCurrent reportAug 21, 2026

How much cash does NVCT have?

Nuvectis Pharma, Inc. (NVCT) reported $31.63M in cash and equivalents in fiscal 2025.

How much debt does NVCT carry?

Nuvectis Pharma, Inc. (NVCT) reported $0.00 of total debt, with net debt of -$31.63M.